Research hub · 8 articles

SARMs & Receptor Selectivity

Selective androgen receptor modulators are small synthetic molecules that bind the androgen receptor without a steroidal scaffold. That single structural difference is the whole point of the class and also the source of most of its analytical difficulty: several of these compounds are chiral, so a certificate that does not state enantiomeric composition is describing a mixture, not a standard.

The literature on this class is thinner than its commercial presence suggests, so these pages spend their space on what is measurable. Eight articles deal with the class directly: an overview of the series and its regulatory record; compound pages for Ostarine, RAD-140, LGD-4033 and Andarine, each with identity data and its own documented off-target story; a page on SR-9009, which is shelved with SARMs commercially but binds REV-ERB rather than the androgen receptor; a head-to-head comparing Ostarine against RAD-140; and an analytical piece on how these materials are actually verified — retention matching, mass confirmation, chiral composition and the adulteration patterns that make label-based identity worthless. Nothing in this cluster should be read as an efficacy claim: these are reference materials for laboratory work.

If the class is new to you, read the overview first and the compound pages second. The overview explains why receptor-selectivity claims are harder to substantiate than the marketing suggests, and the compound pages show what documentation a reference standard should carry before it is used to standardise anything — identity, purity by peak area, and the chiral composition that a bare percentage hides.

Articles in this hub

Related categories

Related tools

More hubs and compound references in the research journal; analytical documentation on the quality page; or request a quote.